Rheumatoid Arthritis
Showing NaN - NaN of 101
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Adalimumab, Upadacitinib Matching Placebo)
Not yet recruiting
- Rheumatoid Arthritis
- Upadacitinib
- +3 more
-
Flagstaff, Arizona
- +190 more
Apr 4, 2023
Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)
Recruiting
- Rheumatoid Arthritis
- ATI-450 50mg oral tablet BID
- +3 more
-
El Cajon, California
- +24 more
Jan 27, 2023
Exactech Shoulder Post Market Clinical Follow-up Study
Recruiting
- Osteo Arthritis Shoulders
- +8 more
-
Laguna Woods, California
- +33 more
Jan 27, 2023
Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)
Completed
- Rheumatoid Arthritis
- ISIS 104838
-
Birmingham, Alabama
- +30 more
Dec 1, 2022
Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)
Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)
Active, not recruiting
- Rheumatoid Arthritis
- Placebo for Adalimumab
- +3 more
-
Birmingham, Alabama
- +369 more
Jun 14, 2022
Rheumatoid Arthritis Trial in United States (Experimental: Arm A: DRL_RI, Arm B: Rituxan®/Mabthera®)
Active, not recruiting
- Rheumatoid Arthritis
- Experimental: Arm A: DRL_RI
- Arm B: Rituxan®/Mabthera®
-
Phoenix, Arizona
- +25 more
Apr 6, 2022
Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))
Completed
- Rheumatoid Arthritis
- SAR153191 (REGN88)
-
Anniston, Alabama
- +334 more
Mar 21, 2022
Rheumatoid Arthritis Trial in Worldwide (Sarilumab, Adalimumab, Placebo (for sarilumab))
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)
Rheumatoid Arthritis Trial in Worldwide (Olokizumab, Placebo)
Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)
Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)
Completed
- Rheumatoid Arthritis
- Olokizumab 64mg q4w
- +3 more
-
Mesa, Arizona
- +244 more
Apr 6, 2021
Rheumatoid Arthritis Trial in Worldwide (etanercept pre-filled syringe subcutaneous injection, Oral methotrexate, Placebo for
Completed
- Rheumatoid Arthritis
- etanercept pre-filled syringe subcutaneous injection
- +4 more
-
Birmingham, Alabama
- +135 more
Nov 24, 2020
Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CDP870))
Completed
- Rheumatoid Arthritis
- Certolizumab pegol (CDP870)
-
Huntsville, Alabama
- +78 more
Nov 26, 2020
Rheumatoid Arthritis Trial in Worldwide (SKI-O-703, Placebo)
Unknown status
- Rheumatoid Arthritis
- SKI-O-703
- Placebo
-
Beverly Hills, California
- +39 more
Oct 8, 2020
Rheumatoid Arthritis Trial in Worldwide (M2591 25 mg QD, M2951 75 mg QD, M2951 50 mg BID)
Completed
- Rheumatoid Arthritis
- M2591 25 mg QD
- +3 more
-
Phoenix, Arizona
- +97 more
Sep 4, 2020
Rheumatoid Arthritis Trial in Australia, United States (Allogeneic Mesenchymal Precursor Cells, Normal Saline)
Completed
- Rheumatoid Arthritis
- Allogeneic Mesenchymal Precursor Cells
- Normal Saline
-
Anniston, Alabama
- +22 more
Jun 25, 2020
Rheumatoid Arthritis Trial in Worldwide (Apremilast 30 mg, Apremilast 20 mg, Placebo)
Terminated
- Rheumatoid Arthritis
- Apremilast 30 mg
- +2 more
-
Gilbert, Arizona
- +49 more
Apr 22, 2020
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Huntsville, Alabama
- +120 more
Mar 16, 2020